Janssen Cilag Ltd

Lobbying Organisation Janssen Cilag Ltd

Date published 21 Sep, 2017

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 May, 2017 to 31 Aug, 2017

Specific Details The Framework Agreement on Medicine Pricing

Intended results To ensure that process for access to new medicines was improved

Name of person primarily responsible for lobbying on this activity Conor Sweeney

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (2-5)

The purpose of the meetings was to update the politicians on the considerable savings that have been achieved as a result of the medicine pricing agreement and inform them that despite the savings achieved, an uncertainty still exists around the reimbursement timelines and funding for new and innovative medicines.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Billy Kelleher TD (Dáil Éireann, the Oireachtas)

Michael McGrath TD (Dáil Éireann, the Oireachtas)

Michael Harty TD (Dáil Éireann, the Oireachtas)

Margaret Murphy O'Mahony TD (Dáil Éireann, the Oireachtas)